Invitae
| Company type | Public |
|---|---|
| Expert Market: NVTAQ | |
| Industry | Genetic testing |
| Founded | 2010 |
| Headquarters | San Francisco, California, U.S. |
Key people | Kenneth D. Knight (CEO) |
| Revenue | US$279.6 million (2020) |
| US$–608.9 million (2020) | |
| Website | www |
Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012.
In 2017, Invitae acquired Good Start Genetics and CombiMatrix. In 2020, Invitae announced the acquisition of ArcherDX for $1.4 billion. In 2021, Invitae announced the acquisition of health care AI startup Ciitizen for $325 million.
In early 2024, Invitae filed for Chapter 11 bankruptcy protection, and later announced an agreement for an acquisition by Labcorp.